Sarah Flanagan
Royal Devon and Exeter Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sarah Flanagan.
The Journal of Clinical Endocrinology and Metabolism | 2017
Bing Han; Zainab Mohamed; Maria Salomon Estebanez; Ross Craigie; Melanie Newbould; Edmund Cheesman; Raja Padidela; Mars Skae; Matthew Johnson; Sarah Flanagan; Sian Ellard; Karen E. Cosgrove; Indraneel Banerjee; Mark J. Dunne
Objectives: We aimed to characterize mosaic populations of pancreatic islet cells from patients with atypical congenital hyperinsulinism in infancy (CHI‐A) and the expression profile of NKX2.2, a key transcription factor expressed in &bgr;‐cells but suppressed in &dgr;‐cells in the mature pancreas. Patients/Methods: Tissue was isolated from three patients with CHI‐A following subtotal pancreatectomy. CHI‐A was diagnosed on the basis of islet mosaicism and the absence of histopathological hallmarks of focal and diffuse CHI (CHI‐D). Immunohistochemistry was used to identify and quantify the proportions of insulin‐secreting &bgr;‐cells and somatostatin‐secreting &dgr;‐cells in atypical islets, and results were compared with CHI‐D (n = 3) and age‐matched control tissues (n = 3). Results: In CHI‐A tissue, islets had a heterogeneous profile. In resting/quiescent islets, identified by a condensed cytoplasm and nuclear crowding, &bgr;‐cells were reduced to <50% of the total cell numbers in n = 65/70 islets, whereas &dgr;‐cell numbers were increased with 85% of islets (n = 49/57) containing >20% &dgr;‐cells. In comparison, all islets in control tissue (n = 72) and 99% of CHI‐D islets (n = 72) were composed of >50% &bgr;‐cells, and >20% &dgr;‐cells were found only in 12% of CHI‐D (n = 8/66) and 5% of control islets (n = 3/60). Active islets in CHI‐A tissue contained proportions of &bgr;‐cells and &dgr;‐cells similar to those of control and CHI‐D islets. Finally, when compared with active islets, quiescent islets had a twofold higher prevalence of somatostatin/NKX2.2+ coexpressed cells. Conclusions: Marked increases in NKX2.2 expression combined with increased numbers of &dgr;‐cells strongly imply that an immature &dgr;‐cell profile contributed to the pathobiology of CHI‐A.
Frontiers in Endocrinology | 2018
Ross Craigie; Maria Salomon-Estebanez; Daphne Yau; Bing Han; Walaa Mal; Melanie Newbould; Edmund Cheesman; Stefania Bitetti; Zainab Mohamed; Rakesh Sajjan; Raja Padidela; Mars Skae; Sarah Flanagan; Sian Ellard; Karen E. Cosgrove; Indraneel Banerjee; Mark J. Dunne
Background: Congenital Hyperinsulinism (CHI) is an important cause of severe and persistent hypoglycaemia in infancy and childhood. The focal form (CHI-F) of CHI can be potentially cured by pancreatic lesionectomy. While diagnostic characteristics of CHI-F pancreatic histopathology are well-recognized, correlation with clinical phenotype has not been established. Aims: We aimed to correlate the diversity in clinical profiles of patients with islet cell organization in CHI-F pancreatic tissue. Methods: Clinical datasets were obtained from 25 patients with CHI-F due to ABCC8/KCNJ11 mutations. 18F-DOPA PET-CT was used to localize focal lesions prior to surgery. Immunohistochemistry was used to support protein expression studies. Results: In 28% (n = 7) of patient tissues focal lesions were amorphous and projected into adjoining normal pancreatic tissue without clear delineation from normal tissue. In these cases, severe hypoglycaemia was detected within, on average, 2.8 ± 0.8 (range 1–7) days following birth. By contrast, in 72% (n = 18) of tissues focal lesions were encapsulated within a defined matrix capsule. In this group, the onset of severe hypoglycaemia was generally delayed; on average 46.6 ± 14.3 (range 1–180) days following birth. For patients with encapsulated lesions and later-onset hypoglycaemia, we found that surgical procedures were curative and less complex. Conclusion: CHI-F is associated with heterogeneity in the organization of focal lesions, which correlates well with clinical presentation and surgical outcomes.
Diabetologia | 2018
Abdelhadi M. Habeb; Sarah Flanagan; Mohamed A. Zulali; Mohamed A. Abdullah; Renata Pomahačová; Veselin Boyadzhiev; Lesby E. Colindres; Guillermo V. Godoy; Thiruvengadam Vasanthi; Ramlah Al Saif; Aria Setoodeh; Amirreza Haghighi; Alireza Haghighi; Yomna Shaalan; Andrew T. Hattersley; Sian Ellard; Elisa De Franco
/data/revues/00223476/unassign/S0022347614008476/ | 2014
Yanqin Shi; Hima Bindu Avatapalle; Mars Skae; Raja Padidela; Melanie Newbould; Lindsey Rigby; Sarah Flanagan; Sian Ellard; Jacques Rahier; Peter Clayton; Mark J. Dunne; Indraneel Banerjee; Karen E. Cosgrove
Endocrine Abstracts | 2018
Antonia Dastamani; Daphne Yau; Clare Gilbert; Kate Morgan; Elaine O'Shea; Helen Pimlott; Paolo DeCoppi; Ross Craigie; Sarah Flanagan; Jayne Houghton; Senthil Senniappan; Mohammed Didi; Indi Banerjee; Pratik Shah
57th Annual ESPE | 2018
Antonia Dastamani; Eirini Kostopoulou; Emma Clements; Silvana Caiulo; Prateek Shanmugananda; Kate Morgan; Clare Gilbert; Mehul Dattani; Sarah Flanagan; Sian Ellard; Jane Hurst; Pratik Shah
Archive | 2016
Sandra Walton-Betancourth; Pratik Shah; Sarah Flanagan; Sian Ellard; Maria Guemes; Clare Gilbert; Shavel Silvera; Khalid Hussain
Archive | 2016
Carolina Mendoza; Carolina Garfias; Cristian Seiltgens; Ricardo Silva; Isabel Hodgson; Francisca Ugarte; Sarah Flanagan; Sian Ellard; Hernán García
55th Annual ESPE | 2016
Zeynep Siklar; Franco Elisa De; Sarah Flanagan; Sian Ellard; Serdar Ceylaner; Kaan Boztug; Figen Dogu; Aydan Ikinciogullari; Zarife Kuloğlu; Aydan Kansu; Merih Berberoglu
55th Annual ESPE | 2016
Nihal Hatipoglu; Huseyin Demirbilek; Ulku Gul; Zeynep Uzan Tatlı; Sarah Flanagan; Sian Ellard; Franco Elisa De; Selim Kurtoglu